The protective activity of natural flavonoids against osteoarthritis by targeting NF-κB signaling pathway

Yongjun Ye1, Jianguo Zhou2

  • 1Department of Orthopedics, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.

Insights

Natural flavonoids show promise in treating osteoarthritis (OA) by inhibiting the nuclear factor-kappaB (NF-κB) pathway. These compounds may reduce inflammation, cartilage breakdown, and cell death, offering a potential therapeutic strategy for OA management.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Rheumatology

Background:

  • Osteoarthritis (OA) is characterized by chronic joint inflammation.
  • The nuclear factor-kappaB (NF-κB) signaling pathway is a key mediator of inflammatory processes in OA.
  • Inhibiting NF-κB-mediated inflammation presents a potential therapeutic avenue for OA.

Purpose of the Study:

  • To review the efficacy and mechanisms of natural flavonoids in targeting the NF-κB pathway for OA treatment.
  • To explore how structural variations in flavonoids influence their biological actions in OA chondrocytes.
  • To assess the potential of flavonoids as therapeutic agents for OA management.

Main Methods:

  • Literature review focusing on natural flavonoids and their interaction with the NF-κB signaling pathway in OA.
  • Analysis of studies investigating the anti-inflammatory and chondroprotective effects of various flavonoid subclasses.
  • Examination of the molecular mechanisms underlying flavonoid action on NF-κB signaling in OA chondrocytes.

Main Results:

  • Natural flavonoids demonstrate protective effects against OA pathology by inhibiting the NF-κB signaling pathway.
  • Flavonoids may suppress NF-κB-mediated inflammation, extracellular matrix (ECM) degradation, and chondrocyte apoptosis.
  • Differential substitution patterns on flavonoid structures correlate with varying biological activities.

Conclusions:

  • Natural flavonoids hold potential as inhibitors of the NF-κB signaling pathway for OA therapy.
  • Targeting NF-κB with flavonoids could offer a novel strategy for managing osteoarthritis.
  • Further research into specific flavonoids and their mechanisms may lead to effective OA treatments.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K